| Product NDC: | 0904-6290 |
| Proprietary Name: | ATORVASTATIN CALCIUM |
| Non Proprietary Name: | ATORVASTATIN CALCIUM |
| Active Ingredient(s): | 10 mg/1 & nbsp; ATORVASTATIN CALCIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0904-6290 |
| Labeler Name: | Major Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090548 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120529 |
| Package NDC: | 0904-6290-61 |
| Package Description: | 100 TABLET, FILM COATED in 1 BLISTER PACK (0904-6290-61) |
| NDC Code | 0904-6290-61 |
| Proprietary Name | ATORVASTATIN CALCIUM |
| Package Description | 100 TABLET, FILM COATED in 1 BLISTER PACK (0904-6290-61) |
| Product NDC | 0904-6290 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ATORVASTATIN CALCIUM |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120529 |
| Marketing Category Name | ANDA |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | ATORVASTATIN CALCIUM |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |